UBS Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $25.4K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $10.5K | Buy |
|
|||||
|
2023
Q4 | $235 | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $7.34K | Buy |
|
|||||
|
2022
Q3 | $6K | Sell |
|
|||||
|
2022
Q2 | $15K | Sell |
|
|||||
|
2022
Q1 | $20K | Sell |
|
|||||
|
2021
Q4 | $39K | Buy |
|
|||||
|
2021
Q3 | $4K | Buy |
|
|||||
|
2021
Q2 | $1K | Sell |
|
|||||
|
2021
Q1 | $15K | Buy |
|
|||||
|
2020
Q4 | $34K | Sell |
|
|||||
|
2020
Q3 | $23K | Buy |
|
|||||
|
2020
Q2 | $2K | Sell |
|
|||||
|
2020
Q1 | $11K | Buy |
|
|||||
|
2019
Q4 | $14K | Sell |
|
|||||
|
2019
Q3 | $13K | Buy |
|
|||||
|
2019
Q2 | $8K | Sell |
|
|||||
|
2019
Q1 | $14K | Sell |
|
|||||
|
2018
Q4 | $28K | Buy |
|
|||||
|
2018
Q3 | $11K | Sell |
|
|||||
|
2018
Q2 | $44K | Buy |
|
|||||
|
2018
Q1 | $42K | Buy |
|
|||||
|
2017
Q4 | $33K | Buy |
|
|||||
|
2017
Q3 | $33K | Sell |
|
|||||
|
2017
Q2 | $28K | Buy |
|
|||||
|
2017
Q1 | $48K | Sell |
|
|||||
|
2016
Q4 | $79K | Sell |
|
|||||
|
2016
Q3 | $131K | Sell |
|
|||||
|
2016
Q2 | $119K | Buy |
|
|||||
|
2016
Q1 | $107K | Sell |
|
|||||
|
2015
Q4 | $2.76M | Buy |
|
|||||
|
2015
Q3 | $634K | Buy |
|
|||||
|
2015
Q2 | $554K | Buy |
|
|||||
|
2015
Q1 | $569K | Buy |
|
|||||
|
2014
Q4 | $268K | Buy |
|